Board Meeting29 Oct 2026, 07:20 pm
Mangalam Drugs Board Meeting on Nov 5 to Approve Unaudited Financials
AI Summary
Mangalam Drugs & Organics Ltd has announced a Board of Directors meeting scheduled for November 5, 2026. The primary agenda is to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30, 2026. Concurrently, the company has closed its trading window for designated employees and directors from October 1, 2026, until 48 hours after the financial results are announced, in compliance with SEBI's Insider Trading Regulations.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve Unaudited Financial Results for Q2 FY27.
- Results will be Standalone & Consolidated.
- Trading window closed from October 1, 2026.
- Closure is until 48 hours post results announcement.
Price Impact
More from MANGALAM